Difference between revisions of "Pirinen E"
From Bioblast
| Line 15: | Line 15: | ||
{{Labelingperson}} | {{Labelingperson}} | ||
== Participated at == | == Participated at == | ||
* [[IOC106]] | * [[MiPNet20.10 IOC106 Schroecken|IOC106 Schroecken]] | ||
Revision as of 12:17, 24 August 2015
| Name | Pirinen Eija, |
|---|---|
| Institution | University of Helsinki
Research Program for Molecular Neurology University of Helsinki |
| Address | Yliopistonkatu 4, 00100 |
| City | Helsinki |
| State/Province | |
| Country | Finland |
| [email protected] | |
| Weblink | |
| O2k-Network Lab | FI Helsinki Pirinen E |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Van de Weijer 2015 Diabetes | 2015 | van de Weijer T, Phielix E, Bilet L, Williams EG, Ropelle ER, Bierwagen A, Livingstone R, Nowotny P, Sparks LM, Paglialunga S, Szendroedi J, Havekes B, Moullan N, Pirinen E, Hwang JH, Schrauwen-Hinderling VB, Hesselink MK, Auwerx J, Roden M, Schrauwen P (2015) Evidence for a direct effect of the NAD+ precursor acipimox on muscle mitochondrial function in humans. Diabetes 64:1193-201. |
